Evidence map›Paper›PMID 41900282›Full record

ArticleMicroorganisms2026

Ryuichi Saito, Rika Inomata, Dian-Sheng Wang, Satoshi Shimazaki

Abstract read
In one paragraph

Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ryuichi SaitoResearch Division, TOA Biopharma Co., Ltd., 606 Kondoh-cho, Tatebayashi 374-0042, Gunma, Japan.ORCID 0000-0001-5408-2150
Rika InomataResearch Division, TOA Biopharma Co., Ltd., 606 Kondoh-cho, Tatebayashi 374-0042, Gunma, Japan.ORCID 0000-0003-0605-9321
Dian-Sheng WangResearch Division, TOA Biopharma Co., Ltd., 606 Kondoh-cho, Tatebayashi 374-0042, Gunma, Japan.
Satoshi ShimazakiResearch Division, TOA Biopharma Co., Ltd., 606 Kondoh-cho, Tatebayashi 374-0042, Gunma, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactic acid bacteria (LAB) have dominated food fermentation globally and are ingrained in many food cultures. Obesity is a global health concern, and LAB ingestion is known to exert anti-obesity effects in animals. However, the characteristics of individual bacterial strains and their underlying mechanisms require elucidation since the anti-obesity effects can differ with variations in the strain, host, and living environment. In this study, we aimed to evaluate the safety and anti-obesity effects of

Indexed as

Caenorhabditis elegansLactiplantibacillus plantarumobesityprobiotics

Identifiers

PMID41900282
PMCPMC13028613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.